Post-hospitalisation Nutritional Support and Gait Speed in COPD
Primary Purpose
Pulmonary Disease, Chronic Obstructive, Respiratory Tract Diseases, Lung Diseases, Obstructive
Status
Terminated
Phase
Phase 3
Locations
United Kingdom
Study Type
Interventional
Intervention
Food fortification
Oral Nutritional Supplements
Sponsored by
About this trial
This is an interventional supportive care trial for Pulmonary Disease, Chronic Obstructive
Eligibility Criteria
Inclusion Criteria:
- Ability to consent
- Patients at moderate or severe risk of malnutrition
- Adults over the age of 40
- Hospitalised with an AECOPD
Exclusion Criteria:
- Receiving long term parental or enteral nutrition
- Inability to swallow or difficulty liquids
- Lactose intolerance, galactosaemia, cow's milk protein allergy or intolerance
- Co-existing active cancer, progressive neurological condition or active GI disorder.
- Receiving palliative care with expectation of death within 3 months
- Cognitive dysfunction or unable to consent
Sites / Locations
- The Hillingdon Hospital NHS Foundation Trust
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
No Intervention
Arm Label
Food Fortification
Oral Nutritional Supplements
Usual Care
Arm Description
Food Fortification
Oral Nutritional Supplements - Fortisip Compact
Outcomes
Primary Outcome Measures
Change in four-metre gait speed (m/s) following nutritional support
Secondary Outcome Measures
Change in weight (kg) following nutritional support
Change in fat free mass (kg) as measured by bioelectrical impedence following nutritional support
Change in fat free mass index (kg/m2) as measured by bioelectrical impedence following nutritional support
Full Information
NCT ID
NCT02261350
First Posted
May 8, 2014
Last Updated
October 30, 2015
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Collaborators
Medical Research Council, The Hillingdon Hospitals NHS Foundation Trust
1. Study Identification
Unique Protocol Identification Number
NCT02261350
Brief Title
Post-hospitalisation Nutritional Support and Gait Speed in COPD
Official Title
The Effect of Nutritional Support on Gait Speed Following Hospitalisation for Acute Exacerbation of COPD
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Terminated
Study Start Date
January 2014 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
September 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Collaborators
Medical Research Council, The Hillingdon Hospitals NHS Foundation Trust
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To determine the feasibility of delivering different community nutritional interventions to chronic obstructive pulmonary disease (COPD) patients at moderate or severe risk of malnutrition following a hospitalisation for an acute exacerbation of COPD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive, Respiratory Tract Diseases, Lung Diseases, Obstructive, Bronchitis, Chronic, Pulmonary Emphysema
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
22 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Food Fortification
Arm Type
Experimental
Arm Description
Food Fortification
Arm Title
Oral Nutritional Supplements
Arm Type
Experimental
Arm Description
Oral Nutritional Supplements - Fortisip Compact
Arm Title
Usual Care
Arm Type
No Intervention
Intervention Type
Dietary Supplement
Intervention Name(s)
Food fortification
Intervention Type
Dietary Supplement
Intervention Name(s)
Oral Nutritional Supplements
Other Intervention Name(s)
Fortisip Compact, Nutricia Clinical
Primary Outcome Measure Information:
Title
Change in four-metre gait speed (m/s) following nutritional support
Time Frame
Change from baseline to 12 weeks
Secondary Outcome Measure Information:
Title
Change in weight (kg) following nutritional support
Time Frame
Change from baseline to 12 weeks
Title
Change in fat free mass (kg) as measured by bioelectrical impedence following nutritional support
Time Frame
Change from baseline to 12 weeks
Title
Change in fat free mass index (kg/m2) as measured by bioelectrical impedence following nutritional support
Time Frame
Change from baseline to 12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Ability to consent
Patients at moderate or severe risk of malnutrition
Adults over the age of 40
Hospitalised with an AECOPD
Exclusion Criteria:
Receiving long term parental or enteral nutrition
Inability to swallow or difficulty liquids
Lactose intolerance, galactosaemia, cow's milk protein allergy or intolerance
Co-existing active cancer, progressive neurological condition or active GI disorder.
Receiving palliative care with expectation of death within 3 months
Cognitive dysfunction or unable to consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William Man, PhD FRCP
Organizational Affiliation
Royal Brompton & Harefield NHS Foundation Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Hillingdon Hospital NHS Foundation Trust
City
Uxbridge
State/Province
Middlesex
ZIP/Postal Code
UB8 3NN
Country
United Kingdom
12. IPD Sharing Statement
Learn more about this trial
Post-hospitalisation Nutritional Support and Gait Speed in COPD
We'll reach out to this number within 24 hrs